These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17623013)

  • 1. Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential?
    Coll AP
    Clin Sci (Lond); 2007 Aug; 113(4):171-82. PubMed ID: 17623013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity.
    Zemel MB; Shi H
    Nutr Rev; 2000 Jun; 58(6):177-80. PubMed ID: 10885325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial uncoupling in the melanocortin system differentially regulates NPY and POMC neurons to promote weight-loss.
    Michael NJ; Simonds SE; van den Top M; Cowley MA; Spanswick D
    Mol Metab; 2017 Oct; 6(10):1103-1112. PubMed ID: 29031712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in pomc null mice.
    Tung YC; Piper SJ; Yeung D; O'Rahilly S; Coll AP
    Endocrinology; 2006 Dec; 147(12):5940-7. PubMed ID: 16959830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GTRAP3-18 regulates food intake and body weight by interacting with pro-opiomelanocortin.
    Aoyama K; Bhadhprasit W; Watabe M; Wang F; Matsumura N; Nakaki T
    FASEB J; 2018 Jan; 32(1):330-341. PubMed ID: 28904020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feeding effects of melanocortin ligands--a historical perspective.
    Irani BG; Haskell-Luevano C
    Peptides; 2005 Oct; 26(10):1788-99. PubMed ID: 16046247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production.
    Coll AP; Fassnacht M; Klammer S; Hahner S; Schulte DM; Piper S; Tung YC; Challis BG; Weinstein Y; Allolio B; O'Rahilly S; Beuschlein F
    J Endocrinol; 2006 Aug; 190(2):515-25. PubMed ID: 16899584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of blood pressure by central melanocortinergic pathways.
    Maier T; Hoyer J
    Nephrol Dial Transplant; 2010 Mar; 25(3):674-7. PubMed ID: 20061320
    [No Abstract]   [Full Text] [Related]  

  • 9. Lean rats with hypothalamic pro-opiomelanocortin overexpression exhibit greater diet-induced obesity and impaired central melanocortin responsiveness.
    Li G; Zhang Y; Cheng KY; Scarpace PJ
    Diabetologia; 2007 Jul; 50(7):1490-9. PubMed ID: 17505816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin.
    Yaswen L; Diehl N; Brennan MB; Hochgeschwender U
    Nat Med; 1999 Sep; 5(9):1066-70. PubMed ID: 10470087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Homeodomain Transcription Factor NKX2.1 Is Essential for the Early Specification of Melanocortin Neuron Identity and Activates
    Orquera DP; Tavella MB; de Souza FSJ; Nasif S; Low MJ; Rubinstein M
    J Neurosci; 2019 May; 39(21):4023-4035. PubMed ID: 30886014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of central melanocortin signaling in eating disorders.
    Lu XY
    Psychopharmacol Bull; 2001; 35(4):45-65. PubMed ID: 12397856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The catabolic action of insulin in the brain is mediated by melanocortins.
    Benoit SC; Air EL; Coolen LM; Strauss R; Jackman A; Clegg DJ; Seeley RJ; Woods SC
    J Neurosci; 2002 Oct; 22(20):9048-52. PubMed ID: 12388611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The central melanocortin system as a treatment target for obesity and diabetes: A brief overview.
    Goit RK; Taylor AW; Lo ACY
    Eur J Pharmacol; 2022 Jun; 924():174956. PubMed ID: 35430211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 60 YEARS OF POMC: Regulation of feeding and energy homeostasis by α-MSH.
    Anderson EJ; Çakir I; Carrington SJ; Cone RD; Ghamari-Langroudi M; Gillyard T; Gimenez LE; Litt MJ
    J Mol Endocrinol; 2016 May; 56(4):T157-74. PubMed ID: 26939593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocortins and cardiovascular regulation.
    Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
    Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The melanocortin system in control of inflammation.
    Catania A; Lonati C; Sordi A; Carlin A; Leonardi P; Gatti S
    ScientificWorldJournal; 2010 Sep; 10():1840-53. PubMed ID: 20852827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes.
    Mountjoy KG
    Biochem J; 2010 May; 428(3):305-24. PubMed ID: 20504281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in our understanding of melanocortin system in the regulation of food intake.
    Yang YK; Harmon CM
    Obes Rev; 2003 Nov; 4(4):239-48. PubMed ID: 14649374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of melanocortins in the central control of feeding.
    Vergoni AV; Bertolini A
    Eur J Pharmacol; 2000 Sep; 405(1-3):25-32. PubMed ID: 11033311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.